Cipla EU to gain full ownership of Chinese JV through equity purchase

Cipla Jiangsu was established in China on August 8, 2019, as a joint venture between Cipla EU, which currently holds 93.0876% equity, and Jiangsu Xidi Pharmaceuticals. Shares of Cipla Ltd ended at ₹1,643.70, up by ₹6.30, or 0.38%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *